SavedAdd your journal

Journals / Tıp Araştırmaları Dergisi / 2015 / Cilt: 13 - Sayı: 1

Probiotics and Synbiotic Use In Patients with Acute Gastroenteritis Developing After Ampicillin-Sulbactam Using

Ampisilin-Sulbaktam Kullanımı Sonrası Akut Gastroenterit Gelişen Hastalarda Probiyotik ve Sinbiyotiklerin Kullanımı

Mahmut ABUHANDAN
Süleyman GETER1
AHMET GÜZELÇİÇEK
Pages
11–14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: We observed that it is more appropriate to use synbiotic containing preparations to prevent and providing early clinical remission of diarrhea-associated antibiotic

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study aimed to evaluate of the effectiveness of probiotic and synbiotic in patients with acute gastroenteritis developing after ampicillin-sulbactam use.
📊
Key Findings & Data:We were followed by giving synbiotic to 27 and probiotics to 27 placebos to 26 of these patients.
💡
Conclusion & Impact:Conclusions: We observed that it is more appropriate to use synbiotic containing preparations to prevent and providing early clinical remission of diarrhea-associated antibiotic
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: This study aimed to evaluate of the effectiveness of probiotic and synbiotic in patients with acute gastroenteritis developing after ampicillin-sulbactam use. Material & Method: Eighty patients who developing gastroenteritis after antibiotics use were studied. We were followed by giving synbiotic to 27 and probiotics to 27 placebos to 26 of these patients. Results: We were observed that early in the first 24 hours and longest 96 hours the remission of clinical symptoms for all groups who get to study. While clinical improvement and earlier remission of the synbiotic group compared with both the probiotic group and the placebo group were found to be significantly lower (p = 0.04), however, between the probiotic and the placebo-treated groups was not statistically significant (p> 0.05). Conclusions: We observed that it is more appropriate to use synbiotic containing preparations to prevent and providing early clinical remission of diarrhea-associated antibiotic

Özet

Amaç: Bu çalışmada Ampisilin-sulbaktam sonrası akut gastroenterit gelişen hastalarda probiyotik ve sinbiyotiklerin etkinliklerin değerlendirilmesi amaçlandı. Gereç ve Yöntem: antibiyotik kullanımı sonrası gastroenterit gelişen 80 hasta çalışmaya alındı. Bu hastaların 27'sine sinbiyotik, 27'sine probiyotik ve 26'sına plasebo verilerek izleme alındı. Bulgular: Çalışmaya alınan her üç grup için en erken ilk 24 saatte en uzun 96 saat içinde klinik bulguların düzeldiği gözlemlendi. Sinbiyotik verilen grubun klinik düzelmesi hem probiyotik hem de plasebo verilen gruba göre daha erken düzeldiği bulunurken (p=0.04), probiyotik ve plasebo verilen gruplar arasında istatistiksel olarak anlamlı bulunmadı (p>0.05). Sonuç: Antibiyotiklere bağlı gelişen akut gastroenteritin önlenmesi ve erken klinik düzeltmenin sağlanması için sinbiyotik içeren preparatların kullanması daha uygun olduğu görülmüştür

🔖

Cite This Article

ABUHANDAN, M., GETER1, S., GÜZELÇİÇEK, A. (2015). Probiotics and Synbiotic Use In Patients with Acute Gastroenteritis Developing After Ampicillin-Sulbactam Using. Tıp Araştırmaları Dergisi, Cilt: 13 - Sayı: 1, 11–14. https://ajindex.com/articles/361625

References (12)

  1. Güzel Tunçcan Ö, Ulutanı F, Karakuş R. Antibiyotiğe bağlı ishal gelişen nötrpenik ve nötropenik olmayan clostridium difficile toksin sıklığı ve risk faktörlerin analizi. Mikrobiyol Bul 2008; 42: 573-583.
  2. Coşkun T. Pro-, Pre- ve Sinbiyotikler. Çocuk Sağlığı ve Hastalıkları Dergisi. 2006; 49: 128-148.
  3. Hakyemez İN, Şimşek F, Yıldırmak T, Yöntem B, Aksu A. Antibiyotik ilişkili ishal olgularının değerlendirilmesi. Abant Med J 2012;1(1):16-17.
  4. Cremonini F, Di Caro S, Santarelli L, et al. Probiotics in antibiotic-associated diarrhoea. Dig Liver Dis 2002; 34: S78-S80. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: metaanalysis. Br Med J 2002; 324: 1361. Hill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J 2004; 80: 516-526.
  5. Young RJ, Huffman S. Probiotic use in children. J Pediatr Health Care 2003; 17: 277-283.
  6. Vanderhoof JA, Young RJ. Current and potential uses of probiotics. Ann Allergy Asthma Immunol 2004; 93: S33-S37. O'Sullivan GC, Kelly P, O'Halloran S. Probiotics: an emerging therapy. Curr Pharm Des 2005; 11: 3- 10. Penner R, Fedorak RN, Madsen KL. Probiotics and nutreceuticals: non-medicinal treatments of gastrointestinal diseases. Curr Opin Pharmacol 2005; 5: 1-8.
  7. Szajewska H, Mrukowicz JZ. Use of probiotics in children with acute diarrhea. Pediatr Drugs 2005; 7: 111-122.
  8. Sullivan A, Nord CE. Probiotics and gastrointestinal diseases. J Intern Med 2005; 257: 78-92.
  9. Mottet C, Michetti P. Probiotics: wanted dead or alive. Dig Liver Dis 2005; 37: 3-6.
  10. Zubillaga M, Weill R, Postaire E, Goldman C, Caro R, Boccio J. Effect of probiotics and functional foods and their use in different diseases. Nutr Res 2001; 21: 569-579. Isolauri E. Probiotics for infectious diarrhoea. Gut 2003;52:436-7. ESPGHAN Committee on Nutrition. Medical Position Paper; Probiotic Bacteria in Dietetic Products for Infants: A Commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2004;38:365-374.
  11. Akisu M, Baka M, Coker I. Effect of dietary n-3 fatty acids on hypoxia-induced necrotizing enterocolitis in young mice. Biol Neonate 1998;74:31-8. Akova M. Antibiyotikle ilişkili ishalde epidemiyoloji ve risk fak-törleri. ANKEM Derg 2004; 18: 80-81. Doğancı L. Antibiyotiğe bağlı diyare ve Psödomembranöz kolit, İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji 2000; 183-189.
  12. Wiström J, Norrby SR, Myhere EB et al. Frequency of antibiotic-associated diarrhea in 2462 antibiotic-treated hos